Severe Aplastic Anaemia Working Party (SAAWP)
Type d'étude:
Numéro de l'étude:
8409077
Type de traitement à base de cellules souches:
Maladies:
Bone marrow failure
Titre court:
ATG in aPRCA
Objectif principal:
To investigate the effectivity of treatment with ATG in patients with acquired PRCA.
Principaux critères d'inclusion:
Patients are eligible if:
1) they have been diagnosed with acquired PRCA and
2) received ATG treatment between 2000 and 2018.
1) they have been diagnosed with acquired PRCA and
2) received ATG treatment between 2000 and 2018.
Pays:
Investigateur principal:
Stijn Halkes
Coordinateur EBMT de l'étude:
Brian Piepenbroek
E-mail du coordinateur de l'étude:
saawpebmt@lumc.nl